Non-adherence to highly active antiretroviral therapy predicts progression to AIDS

AIDS

Volumn 15, Issue 9, 2001, Pages 1181-1183

  Bangsberg, David R ^a   Perry, Sharon ^b   Charlebois, Edwin D ^a   Clark, Richard A ^b   Roberston, Marjorie ^c   Zolopa, Andrew R ^d   Moss, Andrew ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ALCOHOL RESEARCH GROUP   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; URBAN POPULATION; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HUMANS; TREATMENT REFUSAL; VIRAL LOAD;

EID: 0035876041     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200106150-00015     Document Type: Article

References (16)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators
2. Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, and injection drug users, from 1995 through 1997
3. Survival after introduction of HAART in people with known duration of HIV-1 infection. The CASCADE Collaboration. Concerted Action on SeroConversion to AIDS and Death in Europe
4. Impact of HIV on adult (15-54) mortality in London: 1979-1996
5. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
6. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
7. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: Plasma viral load and CD4+ cell count
8. HIV-1 RNA response to antiretroviral treatment in 1280 participants in the Delta Trial: An extended virology study
9. CD4 cell counts at the third month of HAART may predict clinical failure
10. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
11. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
12. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens
13. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
14. Impact of directly observed therapy on outcomes in HIV clinical trials
15. Non-adherence to triple-combination ART is predictive of AIDS progression and death in HIV+ men and women
16. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions